MODERNA INC reported first-quarter revenue of $389 million, exceeding analyst estimates of $228 million on strong international vaccine sales. International revenue reached $311 million, fueled by partnerships in the United Kingdom, Canada, and Australia. The shift toward global markets offsets declining demand in the United States following recent regulatory and policy changes.

Global Pivot Offsets Domestic Headwinds